Lactobacillus Reuteri DSM 17938 in the Prevention of Antibiotic-associated Diarrhea in Children: Protocol of a Randomized Controlled Trial
Phase of Trial: Phase IV
Latest Information Update: 30 Dec 2016
At a glance
- Drugs Lactobacillus reuteri (Primary)
- Indications Diarrhoea
- Focus Therapeutic Use
- 30 Dec 2016 Last checked against ClinicalTrials.gov record.
- 27 Dec 2016 Planned primary completion date changed from 1 Sep 2018 to 1 Dec 2018.
- 27 Dec 2016 Status changed from not yet recruiting to recruiting.